Researchers have developed a fast, accessible test that could significantly reduce the number of false positives associated with standard serological HIV tests. In a study published in Science Advances , the test showed accuracy on par or better than any other existing approaches when distinguishing individuals with an active HIV infection from those who carry antibodies against HIV due to vaccination.

While there is yet no approved vaccines for HIV, development is underway, with multiple vaccine candidates currently under evaluation in clinical trials. Preventive vaccines are often designed to make the immune system produce antibodies against HIV antigens, including core proteins and glycoproteins that form the viral envelope. However, these antibodies are typically the target of

See Full Page